First-Generation Radiolabeled Cyclic Peptides for Molecular Imaging of Platelet-Derived Growth Factor Receptor α.
PDGFRA
PET
cyclic peptides
thyroid cancer
Journal
Molecular pharmaceutics
ISSN: 1543-8392
Titre abrégé: Mol Pharm
Pays: United States
ID NLM: 101197791
Informations de publication
Date de publication:
17 Aug 2024
17 Aug 2024
Historique:
medline:
17
8
2024
pubmed:
17
8
2024
entrez:
17
8
2024
Statut:
aheadofprint
Résumé
Occult nodal spread and metastatic disease require longstanding imaging and biochemical assessments for thyroid cancer, a disease that has a propensity for diffuse, small-volume disease. We have developed a
Identifiants
pubmed: 39152916
doi: 10.1021/acs.molpharmaceut.4c00549
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM